Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Luzsana Logo
Luzsana CB Rank
935683
Heat Score
38
Luzsana is a biotech company that offers innovative medicine for oncology and nononcology cases at affordable prices, with clinical trials.
Founded
obfuscation
Private Princeton, New Jersey, United States51-100 www.luzsana.com/
Biopharma
Biotechnology
Oncology
Pharmaceutical
Overview

Luzsana
Heat Score
38

Growth Score
pts
in past quarter
Heat Score 38
-21 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Luzsana

CB Rank
935683
Luzsana is a biotech company that offers innovative medicine for oncology and nononcology cases at affordable prices, with clinical trials.
Founded
obfuscation
Private Princeton, New Jersey, United States51-100 www.luzsana.com/
Biopharma
Biotechnology
Oncology
Pharmaceutical

Details

Legal Name Luzsana Biotechnology Inc
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

KRAS-G12D Inhibitor
A targeted therapy for advanced solid tumors with the KRAS G12D mutation, aiming to inhibit cancer progression.
SHR-A1811
A HER2-targeting antibody-drug conjugate (ADC) designed to treat HER2-expressing advanced solid tumors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100
News
Technology
View Tech Report

Monthly Web Visits

302

IT Spend

$306.6KThis year, Luzsana is projected to spend $306.6K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Corporate Trust Logo
Corporate Trust
71
Mezzanine Finance Logo
Mezzanine Finance
68

Active Website Tech Count

7Luzsana is actively using 7 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Mobile Non Scaleable Content.
Sub-Organizations
Frequently Asked Questions

Where is Luzsana's headquarters? Luzsana is located in Princeton, New Jersey, United States.Who are Luzsana's competitors? Alternatives and possible competitors to Luzsana may include Kelun Biotech, Nuvation Bio, and  Legend Biotech.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|